The Form 144 filing is a routine notice of intent to sell by an officer following RSU vesting. The dollar amount is negligible relative to ALLO's market cap, so no material price impact is expected. Monitor for any subsequent Form 4 filings to confirm whether the sale was executed.
Price Chart
Executive Summary
Geoffrey M. Parker, an officer of Allogene Therapeutics, filed a Form 144 notice of intent to sell 100,000 shares of common stock, with an approximate market value of $48,698.28 based on the filing date. The shares were acquired via vesting of restricted stock units under the company's equity compensation plan. This is a routine insider sale of a relatively small position relative to the company's market cap, and does not signal material negative information.
Key Facts
- Insider Geoffrey M. Parker (officer) filed Form 144 to sell 100,000 shares of Allogene Therapeutics common stock.
- Estimated sale value: $48,698.28 based on filing date.
- Shares were acquired on 10/20/2026 via vesting of restricted stock units under the issuer's equity compensation plan.
- The sale is planned to be executed through Morgan Stanley Smith Barney LLC.
Financial Impact
Sale of 100,000 shares valued at approximately $48,698.28, representing a small fraction of the company's market capitalization.
Risk Factors
- Insider selling, even if routine, can create negative sentiment among retail investors.
- If the insider sells a larger portion of holdings than typical, it could signal reduced conviction.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001491874-26-000003 |
| Document: 0001491874-26-000003-index.html | 0001491874-26-000003 |
| Document: 0001491874-26-000003.txt | 0001491874-26-000003 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 144 | $1.25 $1.25 | · 0.00% | ▲ +0.52% | $1.21 (−3.20%) |
Sep 2, 2026 7w ago | 8-K | $1.98 $1.98 | · 0.00% | ▼ −1.05% | $1.21 (−38.89%) |
Aug 21, 2026 9w ago | 144 | $2.03 $2.17 | ▲ +6.90% | ▲ +6.58% | $1.21 (−40.39%) |
Aug 21, 2026 9w ago | EFFECT | $2.09 $2.03 | ▲ +2.87% | ▲ +2.58% | $1.21 (+42.11%) |
Aug 6, 2026 11w ago | Institutional Cluster | $1.97 $2.01 | ▲ +2.03% | ▲ +1.42% | $1.21 (−38.58%) |
Jun 22, 2026 18w ago | 8-K | $2.07 $2.05 | ▲ +0.97% | ▲ +0.92% | $1.21 (+41.55%) |
Jun 22, 2026 18w ago | 424B5 | $2.07 $2.05 | ▲ +0.97% | ▲ +0.92% | $1.21 (+41.55%) |
May 28, 2026 21w ago | DEFA14A | $2.17 $2.15 | ▼ −0.92% | ▼ −1.18% | $1.21 (−44.24%) |
May 28, 2026 21w ago | 8-K | $2.17 $2.15 | ▼ −0.92% | ▼ −1.18% | $1.21 (−44.24%) |
May 28, 2026 21w ago | Press Release | $2.17 $2.15 | ▼ −0.92% | ▼ −1.20% | $1.21 (−44.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers